Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 87

Results For "medicines"

1094 News Found

PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients
Healthcare | February 15, 2022

PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients

The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country


Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane
Biotech | February 14, 2022

Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane

Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific


Novartis India enters sales and distribution agreement with Dr. Reddy’s
News | February 12, 2022

Novartis India enters sales and distribution agreement with Dr. Reddy’s

Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India


Amazon.in launches a storefront for Ayurveda products
News | February 11, 2022

Amazon.in launches a storefront for Ayurveda products

The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands


We expect to turn profitable in two years: M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed
interviews | February 09, 2022

We expect to turn profitable in two years: M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed

MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India


Lupin signs distribution agreement with Medis for Orphan Drug NaMuscla@
News | February 09, 2022

Lupin signs distribution agreement with Medis for Orphan Drug NaMuscla@

NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction


Dr. Reddy's set to acquire Nimbus Health
News | February 03, 2022

Dr. Reddy's set to acquire Nimbus Health

The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients


Universal vaccination for Covid-19 irrational: AIIMS Professor
News | February 03, 2022

Universal vaccination for Covid-19 irrational: AIIMS Professor

The need is to vaccinate people who have not contracted Covid-19


Foreign Direct Investment in pharma grows at rapid pace: Eco Survey
News | January 31, 2022

Foreign Direct Investment in pharma grows at rapid pace: Eco Survey

In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21


Mark Cuban’s online pharmacy set to disrupt drug prices in the US
News | January 27, 2022

Mark Cuban’s online pharmacy set to disrupt drug prices in the US

Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals